1-3 of 3
Sufeng Mao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

Free
Carmine De Angelis, Chandandeep Nagi, Cliff C. Hoyt, Linying Liu, Kristin Roman, Chichung Wang, Yi Zheng, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Paolo Nuciforo, Tao Wang, Anna Tsimelzon, Sufeng Mao, Susan G. Hilsenbeck, Meghana V. Trivedi, Maria Letizia Cataldo, Anne Pavlick, Antonio C. Wolff, Britta Weigelt, Jorge S. Reis-Filho, Aleix Prat, Carolina Gutierrez, Charles Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 738–745.
https://doi.org/10.1158/1078-0432.CCR-19-1402
Published: 03 February 2020
View articletitled, Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy
Open the PDF for Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

Free
Mario Giuliano, Huizhong Hu, Yen-Chao Wang, Xiaoyong Fu, Agostina Nardone, Sabrina Herrera, Sufeng Mao, Alejandro Contreras, Carolina Gutierrez, Tao Wang, Susan G. Hilsenbeck, Carmine De Angelis, Nicholas J. Wang, Laura M. Heiser, Joe W. Gray, Sara Lopez-Tarruella, Anne C. Pavlick, Meghana V. Trivedi, Gary C. Chamness, Jenny C. Chang, C. Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3995–4003.
https://doi.org/10.1158/1078-0432.CCR-14-2728
Published: 31 August 2015
View articletitled, Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy
Open the PDF for Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy in another window
Includes: Supplementary data
Journal Articles

Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

Free
D. Craig Allred, Yun Wu, Sufeng Mao, Iris D. Nagtegaal, Sangjun Lee, Charles M. Perou, Syed K. Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 370–378.
https://doi.org/10.1158/1078-0432.CCR-07-1127
Published: 25 January 2008
View articletitled, Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Open the PDF for Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution in another window
Includes: Supplementary data